[5-Chloro-3-(4-chloro-phenyl)-1-phenyl-1H-pyrazol-4-yl]-methanol, 95.0%, 1g

(2E)-3-(3-fluorophenyl)-1-(4-fluorophenyl)prop-2-en-1-one, 95.0%, 10g

1,4-butanediol, min 99,0 %, pour la synthèse, 10 l, emballage plastique.

1,10-Dichlorodecane>97.0%(GC)25g

3-((3-(N-Cyclopropylsulfamoyl)-7-(2,4-dimethoxypyrimidin-5-yl)quinolin-4-yl)amino)-5-(3,5-difluorophenoxy)benzoic acid, 98%, 25mg

5-Methyl-2-(2-nitrophenyl)oxazole, 95.0%, 100mg

4-Bromo-1-(2-hydroxyethyl)pyridin-2(1H)-one, 98%, 500mg

6-AMINOPYRIDINE-3-SULFONAMIDE, 95.0%, 500mg

3-(Aminomethyl)bicyclo[1.1.1]pentan-1-methanol, 98%, 500mg

3-(2-Chloroethyl)oxazolidin-2-one, 95.0%, 1g

Thalidomide-O-C4-COOH, 100mg

Hexadecyltrimethylammonium Hydroxide (10% in Water)25mL

Boc-L-2-Aminobutyric acid, 97.0%, 5g